Back to Journals » Therapeutics and Clinical Risk Management » Volume 8

Assessment of malignancy risk in patients with multiple sclerosis treated with intramuscular interferon beta-1a: retrospective evaluation using a health insurance claims database and postmarketing surveillance data

Total article views   HTML views PDF downloads Totals
12,641 Dovepress* 10,094+ 1,517 11,611
PubMed Central* 2,547 355 2,902
Totals 12,641 1,872 14,513
*Since 20 June 2012
+Since July 2016

View citations on PubMed Central and Google Scholar